APA Alıntı

Luo, G., Li, Z., Lin, X., Li, X., Chen, Y., Xi, K., . . . Xiang, H. (2021). Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo. Acta Pharm Sin B.

Chicago Stili Alıntı

Luo, Guoshun, et al. "Discovery of an Orally Active VHL-recruiting PROTAC That Achieves Robust HMGCR Degradation and Potent Hypolipidemic Activity In vivo." Acta Pharm Sin B 2021.

MLA Alıntı

Luo, Guoshun, et al. "Discovery of an Orally Active VHL-recruiting PROTAC That Achieves Robust HMGCR Degradation and Potent Hypolipidemic Activity In vivo." Acta Pharm Sin B 2021.